Rodney McCarver, MD
Anesthesiology · Little Rock, ARNPI 1831183193
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 42.2% of the total. 2025 is the largest year on record at $1,070, 4.9 times the $217 reported in 2019. Among anesthesiology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1K
- AbbVie$618
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$218
- Pfizer$197
- Amgen$120
- Lundbeck LLC$88
- plus $760 from 20 others
What the payments were for
- Food & beverage$3,460100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 81 | $1,460 |
| AbbVie(2 entities) | 45 | $618 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $218 |
| Pfizer | 12 | $197 |
| Amgen(2 entities) | 8 | $120 |
| Lundbeck LLC | 5 | $88 |
| Boston Scientific | 3 | $87 |
| Lilly USA, LLC | 5 | $70 |
| Vertex | 3 | $70 |
| Novartis | 3 | $58 |
| Scilex Pharmaceuticals Inc. | 3 | $48 |
| Biodelivery Sciences International, Inc. | 3 | $43 |
| Nevro Corp. | 2 | $40 |
| Globus Medical | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Averitas Pharma Inc. | 2 | $35 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Avanos Medical | 1 | $26 |
| Zyla Life Sciences, Inc. | 2 | $26 |
| Vertos Medical, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Siemens Medical Solutions USA, Inc. | 1 | $19 |
| Shionogi Inc | 1 | $17 |
| Stryker | 1 | $17 |
| Stimwave Technologies Incorporated | 1 | $14 |
How this compares
$3,460 in reported general payments places this provider in the 95th percentile of 300 anesthesiology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 297 | $246,306 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,202 | $59,474 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,456 | $41,833 |
| Xtampza ErOxycodone Myristate | 43 | $29,821 |
| Emgality PenGalcanezumab-Gnlm | 34 | $25,578 |
| Pregabalin | 969 | $21,956 |
| LinzessLinaclotide | 31 | $19,654 |
| Aimovig AutoinjectorErenumab-Aooe | 23 | $19,581 |
| Buprenorphine | 79 | $15,424 |
| Baclofen | 1,235 | $13,449 |
| Morphine Sulfate ErMorphine Sulfate | 420 | $12,476 |
| OxycontinOxycodone Hcl | 27 | $12,395 |
| MovantikNaloxegol Oxalate | 25 | $10,013 |
| Gabapentin | 576 | $8,095 |
| SymproicNaldemedine Tosylate | 17 | $7,570 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $1,460 | $276,127340 claims |
| AbbVieLinzess | $618 | $19,65431 claims |
| Shionogi IncSymproic | $17 | $7,57017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 300 anesthesiology providers in Arkansas.
Other anesthesiology in Little Rock
- Johnathan GoreeLittle Rock$513K
- Julius BaloghLittle Rock$245K
- Gregory SmithLittle Rock$55K
- Brian MalkiLittle Rock$29K
- Aparna JindalLittle Rock$10K
- Jarna ShahLittle Rock$10K
- Brian JansenLittle Rock$8K
- Jaleesa JacksonLittle Rock$4K
- Juan RomanLittle Rock$4K
- Felipe MedeirosLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.